Cancer

INDICATION: Cancer; breast cancer; chronic lymphocytic leukemia (CLL); lymphoma; neuroendocrine tumors

Patient sample, cell culture and mouse studies suggest inhibiting XBP1 or its activator IRE1 could help

Read the full 270 word article

User Sign In